India to United States: Rituximab Export Trade Route
India has recorded 19 verified shipments of Rituximab exported to United States, representing a combined trade value of $312.7K USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $16.5K USD. The leading Indian exporter is DR REDDYS LABORATORIES LIMITED, which accounts for 65% of total export value with 5 shipments worth $202.3K USD. On the buying side, UPS WAREHOUSE is the largest importer in United States with $297.9K USD in purchases. The top 3 suppliers — DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, VEA IMPEX (I) PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Rituximab corridor is one of India's established pharmaceutical export routes, with 19 shipments documented worth a combined $312.7K USD. The route is dominated by DR REDDYS LABORATORIES LIMITED, which alone accounts for roughly 65% of all export value, reflecting the consolidated nature of India's rituximab manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $16.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with rituximab's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 25.2%, placing it at rank #11 among India's top rituximab export destinations globally.
On the import side, key buyers of Indian rituximab in United States include UPS WAREHOUSE, TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF INVOICE RAISED TO- and 7 others. UPS WAREHOUSE is the single largest importer with 6 shipments valued at $297.9K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD ACC (INHYD4)
Market Position
- Global rank#11
- Annual growth+25.2%
- Demand growth+23.1%
- Regulatory ease76/100
Top 10 Indian Rituximab Exporters to United States
Showing top 10 of 5 Indian suppliers exporting Rituximab to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DR REDDYS LABORATORIES LIMITED Avg $40.5K per shipment | 5 | $202.3K | 64.7% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $16.1K per shipment | 6 | $96.9K | 31.0% |
| 3 | VEA IMPEX (I) PRIVATE LIMITED Avg $1.6K per shipment | 5 | $8.1K | 2.6% |
| 4 | KOIT BIOPHARMA PRIVATE LIMITED Avg $2.3K per shipment | 2 | $4.5K | 1.4% |
| 5 | DELON INC. Avg $870 per shipment | 1 | $870 | 0.3% |
This table shows the top 10 of 5 Indian companies exporting rituximab to United States, ranked by total trade value. The listed exporters are: DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, VEA IMPEX (I) PRIVATE LIMITED, KOIT BIOPHARMA PRIVATE LIMITED, DELON INC.. DR REDDYS LABORATORIES LIMITED is the dominant supplier with 5 shipments worth $202.3K USD, giving it a 65% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Rituximab Importers in United States
Showing top 10 of 10 known buyers in United States receiving Rituximab shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian rituximab in United States include UPS WAREHOUSE, TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF INVOICE RAISED TO-, S LOG SA DE CV, COMERCIALIZADORA MEDENOR SA DE CV, among 10 total buyers. The largest importer is UPS WAREHOUSE, accounting for $297.9K USD across 6 shipments — representing 95% of all rituximab imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | UPS WAREHOUSE | 6 | $297.9K | 95.3% |
| 2 | TO THE ORDER OF INVOICE RAISED TO | 4 | $4.5K | 1.5% |
| 3 | TO THE ORDER OF INVOICE RAISED TO- | 1 | $3.6K | 1.1% |
| 4 | S LOG SA DE CV | 1 | $3.0K | 1.0% |
| 5 | COMERCIALIZADORA MEDENOR SA DE CV | 1 | $1.5K | 0.5% |
| 6 | COMERCIALIZADORA MEDENOR | 1 | $870 | 0.3% |
| 7 | ALCAMI CORPORATION | 1 | $768 | 0.2% |
| 8 | ATTN MELISSA WHITE CHARLES RIVER LABORATORIES PA-BIOLOGICS TESTING SOLUTIONS | 1 | $250 | 0.1% |
| 9 | CHARLES RIVER LABORATORIES, INC., | 2 | $183 | 0.1% |
| 10 | CHARLES RIVER LABORATORIES,INC, | 1 | $108 | 0.0% |
Top 10 Rituximab Formulations Imported by United States
Showing top 10 of 17 product formulations shipped on the India to United States Rituximab route, ranked by trade value
United States imports a wide range of rituximab formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — RITUXIMAB PLACEBO 10ML(FOR TESTING PURPO — accounts for $82.3K USD across 1 shipments. There are 17 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RITUXIMAB PLACEBO 10ML(FOR TESTING PURPO | 1 | $82.3K | 26.3% |
| 2 | RITUXIMAB PLACEBO 10MLQTY:4250 VIALSFOR TESTING PURPOSE ONLY | 1 | $82.3K | 26.3% |
| 3 | RITUXIMAB PLACEBO 50MLQTY:1986 VIALSFOR TESTING PURPOSE ONLY | 1 | $77.2K | 24.7% |
| 4 | RITUXIMAB DP 500MGQTY:30 VIALSFOR TESTING PURPOSE ONLY | 1 | $29.1K | 9.3% |
| 5 | RITUXIMAB DP 100MG(FOR TESTING PURPOSE O | 1 | $13.6K | 4.3% |
| 6 | RITUXIMAB DP 100MGQTY:70 VIALSFOR TESTING PURPOSE ONLY | 1 | $13.5K | 4.3% |
| 7 | CONTAIN MEDICINES HARMLESS PHARMACEUTICAL PRODUCTS - MABALL 500MG INJ (1X1 VIAL) RITUXIMAB | 2 | $3.8K | 1.2% |
| 8 | CONTAIN MEDICINES HARMLESS PHARMACEUTICALS PRODUCT- MABALL 500MG INJ (1X1 VIAL)RITUXIMAB | 1 | $3.6K | 1.1% |
| 9 | RITUXIREL 500MG INJ / RITUXIMAB | 1 | $3.0K | 1.0% |
| 10 | MABALL 500MG INJ / RITUXIMAB | 1 | $1.5K | 0.5% |
Showing top 10 of 17 Rituximab formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 74%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ACC (INHYD4) handles the highest volume with 5 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's rituximab exports to United States are driven primarily by a handful of large-scale manufacturers. DR REDDYS LABORATORIES LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, VEA IMPEX (I) PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $16.5K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as rituximab placebo 10mlqty:4250 vialsfor testing purpose only and rituximab placebo 50mlqty:1986 vialsfor testing purpose only, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, UPS WAREHOUSE is the largest importer with 6 shipments worth $297.9K USD — representing 95% of all rituximab imports from India on this route. A total of 10 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $312.7K
- Avg. Shipment
- $16.5K
- Suppliers
- 5
- Buyers
- 10
- Transit (Sea)
- ~24 days
- Annual Growth
- +25.2%
Reverse Direction
United States → India — Rituximab (Import)Other Rituximab Routes
Unlock the Full India to United States Rituximab Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 19 shipments on this route.
Frequently Asked Questions — India to United States Rituximab Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Rituximab to United States?
The leading Indian exporters of Rituximab to United States are DR REDDYS LABORATORIES LIMITED, DR.REDDY'S LABORATORIES LTD, VEA IMPEX (I) PRIVATE LIMITED. DR REDDYS LABORATORIES LIMITED holds the largest market share at approximately 65% of total trade value on this route.
Q What is the total value of Rituximab exports from India to United States?
India exports Rituximab to United States worth approximately $312.7K USD across 19 recorded shipments. The average value per shipment is $16.5K USD.
Q Which ports does India use to ship Rituximab to United States?
The most active port of origin is HYDERABAD ACC (INHYD4) with 5 shipments. Indian exporters primarily use sea freight for this route, with 74% of shipments going by sea and 22% by air.
Q How long does shipping take from India to United States for Rituximab?
The average transit time for Rituximab shipments from India to United States is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Rituximab trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.2% with demand growth tracking at 23.1%. The route is ranked #11 among India's top Rituximab export destinations globally.
Q How many suppliers are active on the India to United States Rituximab route?
There are currently 5 active Indian suppliers exporting Rituximab to United States. The market is moderately concentrated with DR REDDYS LABORATORIES LIMITED accounting for 65% of total shipment value.
Q Who are the main importers of Rituximab from India in United States?
The leading importers of Indian Rituximab in United States include UPS WAREHOUSE, TO THE ORDER OF INVOICE RAISED TO, TO THE ORDER OF INVOICE RAISED TO-, S LOG SA DE CV, COMERCIALIZADORA MEDENOR SA DE CV. UPS WAREHOUSE is the largest buyer with 6 shipments worth $297.9K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Rituximab.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 10 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 19 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
19 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists